Metabolon, Inc., a leader in the discovery of biomarkers using metabolomics, today announced the close of an $8 million Series B funding round. Sevin Rosen Funds (Palo Alto, CA) led the round with participation from all existing investors including The Aurora Funds (Durham, NC) and The Trelys Funds (Columbia, SC). A new investor, Harris & Harris Group (New York, NY), also contributed to the financing.
